Actinogen Medical Limited (ASX:ACW)
Share Pricing & News Healthcare

AUD 0.12

0 (0%)
(As on 2022-12-07 11:20:09 AEDT)
Previous Close Open Close*
0.12 0.12 0.12
Market Cap Dividend Yield (Annualized)
AUD 215.687M 0.00%

Day Range
0.115L 0.12 H
0.04L 0.16 H

Chart Price & Information

Last Trade 0.12
Change% 0.0000
52 W H/L 0.160/0.040
EBITDA -9.078M
NPAT After Abnormal Items -9.497M
Equity 21.74M
ROE% -43.69%
Total Liabilities 1.566M
Total Revenue 3.653M
Cash and Cash Equivalents 16.37M

Stock Information

Share price 0.12
Market Cap 215.687M
Price/Gross Cash Flow -14.33
Dividend Yield Excluding Special 0.00%
Ending Shares 1.796B
52-Week Range 0.160-0.040
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.01
P/E ratio 0.000
Sector P/E --
EPS -0.55
Net Profit Margin (%) --
Gross Cash Flows Per Share -0.00
Net Gearing -74.54%
Sales Per Share 0.00
Book Value Per Share 0.01

Similar Companies

Related Articles

About Company

Actinogen Medical is an Australian based biotechnology company. The company is engaged in the treatment of age-related neurodegenerative diseases and Alzheimer. The company focuses on treating cognitive decline through the development of lead compound Xanamem that blocks the production of cortisol in the brain.

Corporate Information

Suite 901, Level 9, 109Pitt Street, SYDNEY, NSW, AUSTRALIA, 2000

Phone:+61 2 8964 7401



Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2023-10-13 2023
Report (Annual) 2023-08-24 2023
Report (Prelim) 2023-08-24 2023
Report (Interim) 2023-02-23 2023